Researchers analyzing gait in people with multiple sclerosis (MS) using wearable inertial sensors have established two new and highly sensitive observer-independent measures of disability…
Margarida Azevedo, MSc
Margarida graduated with a BS in Health Sciences from the University of Lisbon and a MSc in Biotechnology from Instituto Superior Técnico (IST-UL). She worked as a molecular biologist research associate at a Cambridge UK-based biotech company that discovers and develops therapeutic, fully human monoclonal antibodies.
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Articles by Margarida Azevedo, MSc
MS Researchers Create a Nanoparticle Drug Able to Stop Inflammation and Autoimmune Attacks in Mice
Researchers, working on an animal model and human cells, discovered a mechanism to halt autoimmune disease damage and developed of a…
Biogen is launching an initiative developed with the assistance of clinical experts — the 1MSg campaign — to educate and encourage…
Dr. Timothy Coetzee from the National Multiple Sclerosis Society will present an overview of the objectives and achievements of…
Dr. Wayne Moore, from the University of British Columbia and the Vancouver General Hospital, will present an overview and analysis…
Researchers from the University of Tennessee Health Science Center plan to present the results of a study investigating the contribution of…
Scientists from the Neuroimmunological Diseases Unit at the National Institutes of Health (NIH) will present results of a study investigating several…
Anavex Life Sciences, a biopharmaceutical company focused on the development of new therapies for neurodegenerative and central nervous system…
RedHill Biopharma, Ltd., an Israeli biopharmaceutical company focused on the development and commercialization of oral-administered small-molecule medicines for the…
Taste deficits are considerably more prevalent in multiple sclerosis (MS) patients than previously thought, and correlate directly with the severity…
Synthetic Biologics, Inc., a clinical stage company focused on the development of therapeutics to protect the microbiome and to…
In a new study using several mouse models of human immune-mediated inflammatory diseases, including multiple sclerosis (MS), researchers found that…
RegeneRx Biopharmaceuticals, Inc., announced the publication of a research article detailing the process by which Thymosin beta 4 (Tβ4), the company’s…
Researchers developed a new way of using MRI (magnetic resonance imaging) to better distinguish multiple sclerosis (MS)-related “white spots” from similar…
Researchers identified a new mechanism in the progression of multiple sclerosis (MS) that might explain the cognitive impairment and decline…
Researchers have described the mechanisms by which cell precursors of oligodendrocytes — the cells responsible for the generation of myelin…
Researchers have discovered a protein regulator that leads to autoimmune inflammation in multiple sclerosis (MS) patients, a possibly important discovery because…
In a new study, researchers at the Scripps Research Institute (TSRI) uncovered the molecular mechanisms behind the perceived clinical efficacy of a specific…
The Multiple Sclerosis Society of Canada recently published a report documenting and summarizing the most important developments in multiple sclerosis…
New research evaluating fingolimod’s clinical efficacy, safety, and tolerability in patients with relapsing-remitting multiple sclerosis (RRMS) largely supported its use,…
In a new study, researchers found that additives common to processed foods can damage the tight junctions that protect the…
Results from a small pilot study indicated that high-dose vitamin D supplementation is safe and tolerable in patients with multiple…
In a new study, researchers evaluated the effect of dalfampridine treatment in people with multiple sclerosis (MS) and observed significant…
The upcoming 9th annual “Glial-neuronal Interactions in Health and Disease” symposium will bring together nearly 200 neuroscientists — focused on neuron and glial cell…
In a new study, researchers from the University of Toronto, Canada, uncovered the process behind the formation and maintenance of…
Addex Therapeutics, a biopharmaceutical company developing novel small molecule allosteric modulators for neurological disorders, recently announced the publication of…
In a new study, researchers at UT Southwestern Medical Center in Texas and The Scripps Research Institute in California discovered that…
The Fifth Tykeson Fellows Conference brought senior multiple sclerosis (MS) scientists together with nearly 100 young research and clinical fellows from the National…
Researchers demonstrated a process that prevented an induced autoimmune disease from taking hold in the central nervous system of mice, and…
In a new study, researchers have revealed the previously unknown function of the FAM126A gene in supporting myelination (the formation…